Becton Dickinson & Co
XTER : BOXUSA·Healthcare·Medical Devices & Instruments·Ordinary Shares
€147.70
−1.25 (−0.84%)latest daily quoteMarket Cap
€42.02B
Enterprise Value
€58.20B
P/E (TTM)
27.98
P/B
1.93
Net Cash / (Debt)
−€16.05B
52-Week Range
€112 — €156
5-Year Range
€112 — €207
Avg Volume (3M)
112
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
Employees72,000IPOSep 25, 1963SIC3841HQ1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
to
Financials (EUR)
Profitability
Metric
Current
Margins
Gross Margin
46.1%
Operating Margin
14.2%
EBITDA Margin
23.0%
Net Margin
8.0%
OCF Margin
15.3%
FCF Margin
11.8%
Returns on Capital
ROE
6.9%
ROA
3.2%
ROIC
5.8%
ROCE
5.5%
ROC (Greenblatt)
29.6%
3Y ROIIC
41.4%
Consistency
Years Profitable / 10Y
10
Valuation
Metric
Current
Earnings Multiples
P/E (TTM)
27.98
Forward P/E
14.06
P/E ex-NRI
12.35
Shiller P/E (CAPE)
32.04
Cash Flow Multiples
P/FCF
18.72
P/OCF
14.51
P/Owner Earnings
20.71
FCF Yield
5.39%
Enterprise Value Multiples
EV / EBIT
26.19
EV / Forward EBIT
32.99
EV / EBITDA
13.38
EV / Forward EBITDA
15.44
EV / Revenue
3.08
EV / Forward Revenue
3.45
Asset / Sales
P/S
2.25
P/B
1.93
P/Tangible Book
—
Growth-Adjusted
PEG
1.60
Capital Returns
Metric
Current
Dividends
Dividend Yield (TTM)
2.46%
Forward Dividend Yield
2.39%
3Y Dividend Growth
6.1%
Payout Ratio
0.30
5Y Yield on Cost
3.17%
Buybacks & Dilution
3Y Buyback Ratio
−0.20%
5Y Share Change
2.5%
Combined
Shareholder Yield
2.37%
Balance Sheet
Metric
Current
Leverage
Debt / Equity
0.77
Gross Debt / EBITDA
3.87
Cash / Debt
0.04
Equity / Assets
0.46
Coverage
Interest Coverage
5.08
Short-Term Liquidity
Current Ratio
1.05
Quick Ratio
0.58
Cash Ratio
0.09
Composite Scores
Piotroski F-Score
7
Altman Z-Score
1.98
Split History
Date
Split
No split history found.
Ex-date
Amount
Pay date
2026-03-10
$1.05
2026-03-31
2025-12-08
$1.05
2025-12-31
2025-09-08
$1.04
2025-09-30
2025-06-09
$1.04
2025-06-30
2025-03-10
$1.04
2025-03-31
2024-12-09
$1.04
2024-12-31
2024-09-09
$0.95
2024-09-30
2024-06-10
$0.95
2024-06-28
2024-03-07
$0.95
2024-03-29
2023-12-07
$0.95
2023-12-29
10 of 33
View allDate
Transcript
Type
2026-08-06
Q3 2026 Becton Dickinson and Co Earnings Call Transcript
Earnings Call
2026-05-07
Q2 2026 Becton Dickinson and Co Earnings Call Transcript
Earnings Call
2026-03-10
Becton Dickinson and Co at Barclays Global Healthcare Conference Transcript
Conference Presentations
2026-02-09
Q1 2026 Becton Dickinson and Co Earnings Call Transcript
Earnings Call
2026-01-27
Becton Dickinson and Co Annual Shareholders Meeting Transcript
Shareholders and Annual Meetings
2025-11-06
Q4 2025 Becton Dickinson and Co Earnings Call Transcript
Earnings Call
2025-08-07
Q3 2025 Becton Dickinson and Co Earnings Call Transcript
Earnings Call
2025-05-01
Q2 2025 Becton Dickinson and Co Earnings Call Transcript
Earnings Call
2025-02-06
Q1 2025 Becton Dickinson and Co Earnings Call Transcript
Earnings Call
2024-11-07
Q4 2024 Becton Dickinson and Co Earnings Call Transcript
Earnings Call
10 of 89
5-Step DuPont Analysis
ROE %
6.70%
×
×
Net Margin %
7.98%
×
×
Operating Margin %
14.13%
Operating Income
€2.71B
÷
Revenue
€19.16B
×
Tax Burden
0.8915
Net Income
€1.53B
÷
Pretax Income
€1.72B
×
Interest Burden
0.6335
Pretax Income
€1.72B
÷
Operating Income
€2.71B
×
Asset Turnover
0.39
÷
Revenue
€19.16B
÷
Average Total Assets
€49.52B
Begin Total Assets
€52.20B
End Total Assets
€46.83B
×
Equity Multiplier
2.17
÷
Avg Total Assets
€49.52B
÷
Avg Stockholders Equity
€22.83B
Begin Equity
€24.07B
End Equity
€21.59B